Where it
all started
2013
The Idea is Born
In 2013, whilst doing her PhD in Biomedical Engineering at Oxford, Katerina presented for the first time the idea behind Oxford Heartbeat to a wider audience at the Falling Walls Conference on Future Breakthroughs in Science and Society, and won the title “Young Innovator of the Year”.
2015
Company Incorporated
Oxford Heartbeat was incorporated on 14th July 2015.
2016
Our First Grant
Our first (of many) Innovate UK grants. This grant was to explore the idea (Proof of Market), and gave us the opportunity to interview 34 clinicians to understand the clinical need.
2017
Our First Fellowship
We joined the Royal Academy of Engineering Fellowship programme. Awarded another Innovate UK grant to develop a Proof of Concept for cerebral stenting and received an NHS Innovation Award from Health Enterprise East (HEE).
2018
Best UK Health Startup
Oxford Heartbeat is named Best UK Healthcare Start-up of 2018 by WIRED.
2019
Certification
We are legitimately certified as a medical device company. Obtained ISO13485 certification as a medical device company and passed a BSI audit with only two minors (for those who don’t know, that’s no easy feat).
2020
Clinical Trials
We received the prestigious AI in Health and Care Awards from NHSx and NIHR (one of 42 winners out of ~530) and this funds our prospective clinical trial. Also we had our first installation of PreSize® at St George’s hospital London.
2021
Momentum
PreSize® is used in real world clinical settings. We obtain the CE mark, and our declaration of conformity signed. First live patient in Leeds Teaching Hospital. The team hits double digits.
2023
Growth
We are featured by The Times as a prominent AI start-up. 100 patients and counting participating in the PreSize® clinical trial, shown in action on the BBC.
